Shenzhen Kangtai Biological Products300601.SZValuation Analysis

As of Oct 19, 2026, Shenzhen Kangtai Biological Products (300601.SZ) trades at a P/E of 167.00x, P/B of 1.53x, P/S of 5.45x, and a dividend yield of 0.28%.
Longitudinal percentile comparison: P/E sits at the 76th percentile over the trailing 10Y window (vs. 67th percentile over 3Y); P/B sits at the 3rd percentile over the trailing 10Y window (vs. 9th percentile over 3Y); P/S sits at the 3rd percentile over the trailing 10Y window (vs. 9th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 89th percentile within its industry and the 89th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.28%, ranking at the 56th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 73.5 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Shenzhen Kangtai Biological Products operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.